Taking advantage of the inducer-free aggregation and cytotoxicity of hyperphosphorylated tau produced by the PIMAX approach [58, 59] (see below), a pilot screen identified apomorphine and raloxifene [58], two prescription drugs shown to preserve the memory of transgenic mice [60] and to reduce the risks of dementia in humans [61], respectively. This evidence concerns the gene MAPT and dementia.